학술논문
Optimal timing of nirmatrelvir/ritonavir treatment after COVID-19 symptom onset or diagnosis: target trial emulation
Document Type
Article
Author
Source
In: Nature Communications . (Nature Communications, December 2023, 14(1))
Subject
Language
English
ISSN
20411723